Uploads Contact
/
Login Upload

  • Search Results for '2013 Guidance 201 4 2 Ministerial'

Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination
Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination
test
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment
kittie-lecroy
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT
myesha-ticknor
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
pamella-moone
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements
tawny-fly
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE
conchita-marotz
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
cheryl-pisano
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New
calandra-battersby
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
briana-ranney
Guidance for Industry Safety Considerations for Container Labels and Carton Labeling
Guidance for Industry Safety Considerations for Container Labels and Carton Labeling
liane-varnes
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits
pasty-toler
Guidance for Industry InternetSocial Media latforms with Character Space Limitations
Guidance for Industry InternetSocial Media latforms with Character Space Limitations
alida-meadow
Consolidated Seasonal Rainfall Guidance for Africa
Consolidated Seasonal Rainfall Guidance for Africa
mitsue-stanley
Jeff Mealiffe
Jeff Mealiffe
alexa-scheidler
Consolidated Seasonal Rainfall Guidance for
Consolidated Seasonal Rainfall Guidance for
calandra-battersby
Mobile Working Group Session
Mobile Working Group Session
min-jolicoeur
Yr 11: Guidance for using the Mock Exam Booklet- 2013
Yr 11: Guidance for using the Mock Exam Booklet- 2013
celsa-spraggs
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE
karlyn-bohler
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
stefany-barnette
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
liane-varnes
Guidance & Counseling
Guidance & Counseling
tatiana-dople
Significantly Altered Guidance November 2013 Clarification of the Phr
Significantly Altered Guidance November 2013 Clarification of the Phr
pamella-moone
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing
giovanna-bartolotta
November 2012
November 2012
sherrill-nordquist